Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306K Sell
2,062
-233
-10% -$38.8K ﹤0.01% 2123
2026
Q1
$482K Sell
2,295
-1,021
-31% -$257K ﹤0.01% 1716
2025
Q4
$941K Sell
3,316
-1,162
-26% -$363K ﹤0.01% 1252
2025
Q3
$1.38M Buy
4,478
+440
+11% +$138K 0.01% 936
2025
Q2
$1.27M Buy
4,038
+2,138
+113% +$617K 0.01% 867
2025
Q1
$492K Buy
1,900
+656
+53% +$178K 0.01% 1142
2024
Q4
$331K Buy
1,244
+342
+38% +$86.1K ﹤0.01% 1282
2024
Q3
$217K Buy
+902
New +$185K ﹤0.01% 1269

Other funds holding PODD

&Partners's PODD Position: Q2 2026 in Review

&Partners reduced its Insulet (PODD) stake by 10% in Q2 2026, selling an estimated $38.8K and leaving 2,062 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

&Partners first reported a position in PODD in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.38M in Q3 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • &Partners held 2,062 shares of Insulet worth $306K as of Q2 2026.
  • &Partners sold 233 Insulet shares in Q2 2026, an estimated $38.8K.
  • Insulet made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2123 holding.
  • &Partners first reported a position in Insulet in Q3 2024 and has held it in 8 quarters since.
  • &Partners's Insulet position peaked at $1.38M in Q3 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.